Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Imperfect oligodendrocytic and neuronal differentiation of glioblastoma cells.

Wolańczyk M, Hułas-Bigoszewska K, Witusik-Perkowska M, Papierz W, Jaskólski D, Liberski PP, Rieske P.

Folia Neuropathol. 2010;48(1):27-34.

2.

Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors.

Rieske P, Golanska E, Zakrzewska M, Piaskowski S, Hulas-Bigoszewska K, Wolańczyk M, Szybka M, Witusik-Perkowska M, Jaskolski DJ, Zakrzewski K, Biernat W, Krynska B, Liberski PP.

BMC Cancer. 2009 Feb 14;9:54. doi: 10.1186/1471-2407-9-54.

3.

Successful elimination of non-neural cells and unachievable elimination of glial cells by means of commonly used cell culture manipulations during differentiation of GFAP and SOX2 positive neural progenitors (NHA) to neuronal cells.

Witusik M, Piaskowski S, Hulas-Bigoszewska K, Zakrzewska M, Gresner SM, Azizi SA, Krynska B, Liberski PP, Rieske P.

BMC Biotechnol. 2008 Jul 19;8:56. doi: 10.1186/1472-6750-8-56.

4.

Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.

Kawasoe T, Takeshima H, Yamashita S, Mizuguchi S, Fukushima T, Yokogami K, Yamasaki K.

J Neurosurg. 2015 Feb;122(2):317-23. doi: 10.3171/2014.10.JNS132159. Epub 2014 Nov 21.

PMID:
25415071
6.

Human periapical cyst-mesenchymal stem cells differentiate into neuronal cells.

Marrelli M, Paduano F, Tatullo M.

J Dent Res. 2015 Jun;94(6):843-52. doi: 10.1177/0022034515570316. Epub 2015 Feb 11.

PMID:
25672890
7.
8.

Endothelial cells induce cancer stem cell features in differentiated glioblastoma cells via bFGF.

Fessler E, Borovski T, Medema JP.

Mol Cancer. 2015 Aug 19;14:157. doi: 10.1186/s12943-015-0420-3.

9.

Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential.

Stockhausen MT, Kristoffersen K, Stobbe L, Poulsen HS.

Cancer Biol Ther. 2014 Feb;15(2):216-24. doi: 10.4161/cbt.26736. Epub 2013 Nov 1.

10.

YB-1 bridges neural stem cells and brain tumor-initiating cells via its roles in differentiation and cell growth.

Fotovati A, Abu-Ali S, Wang PS, Deleyrolle LP, Lee C, Triscott J, Chen JY, Franciosi S, Nakamura Y, Sugita Y, Uchiumi T, Kuwano M, Leavitt BR, Singh SK, Jury A, Jones C, Wakimoto H, Reynolds BA, Pallen CJ, Dunn SE.

Cancer Res. 2011 Aug 15;71(16):5569-78. doi: 10.1158/0008-5472.CAN-10-2805. Epub 2011 Jul 5.

11.

ZNF238 is expressed in postmitotic brain cells and inhibits brain tumor growth.

Tatard VM, Xiang C, Biegel JA, Dahmane N.

Cancer Res. 2010 Feb 1;70(3):1236-46. doi: 10.1158/0008-5472.CAN-09-2249. Epub 2010 Jan 26.

12.

Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.

Eimer S, Dugay F, Airiau K, Avril T, Quillien V, Belaud-Rotureau MA, Belloc F.

Neuro Oncol. 2012 Dec;14(12):1441-51. doi: 10.1093/neuonc/nos266. Epub 2012 Oct 26.

13.

Developmental expression of fibroblast growth factor (FGF) receptors in neural stem cell progeny. Modulation of neuronal and glial lineages by basic FGF treatment.

Reimers D, López-Toledano MA, Mason I, Cuevas P, Redondo C, Herranz AS, Lobo MV, Bazán E.

Neurol Res. 2001 Sep;23(6):612-21.

PMID:
11547930
16.

Selective specification of CNS stem cells into oligodendroglial or neuronal cell lineage: cell culture and transplant studies.

Espinosa-Jeffrey A, Becker-Catania SG, Zhao PM, Cole R, Edmond J, de Vellis J.

J Neurosci Res. 2002 Sep 15;69(6):810-25.

PMID:
12205675
17.
18.

Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.

Garner JM, Ellison DW, Finkelstein D, Ganguly D, Du Z, Sims M, Yang CH, Interiano RB, Davidoff AM, Pfeffer LM.

PLoS One. 2015 May 8;10(5):e0125838. doi: 10.1371/journal.pone.0125838. eCollection 2015. Erratum in: PLoS One. 2015;10(12):e0145052.

19.
20.

Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells.

Dong Y, Han Q, Zou Y, Deng Z, Lu X, Wang X, Zhang W, Jin H, Su J, Jiang T, Ren H.

Mol Cell Biochem. 2012 Nov;370(1-2):89-102. doi: 10.1007/s11010-012-1401-0. Epub 2012 Jul 25.

PMID:
22829019

Supplemental Content

Support Center